Key facts
- This page summarizes David R. Purdue's Form 4/A - Amendment filing for AbbVie Inc. (ABBV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Mar 2026, 17:00.
David R. Purdue - 27 Feb 2026 Form 4/A - Amendment Insider Report for AbbVie Inc. (ABBV)
- Reporting relationship
- SVP, Controller
- Issuer ticker
- ABBV
- Reported as of
- 27 Feb 2026
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 11 Mar 2026, 17:00:20 UTC
- Original report date
- 03 Mar 2026
- Prior SEC filing
- 20 Feb 2026
- Next SEC filing
- 06 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ T.O. Odutayo, Attorney-in-Fact for David R. Purdue
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
David R. Purdue filed Form 4/A - Amendment for AbbVie Inc. (ABBV) on 11 Mar 2026.
Change
- Previous filing in this sequence was filed on 20 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reporting Owners (1)
CIK 0002057696
Primary reporting owner
Purdue David Ryan
- Relationship
- SVP, Controller
- Address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO
- Signature
- /s/ T.O. Odutayo, Attorney-in-Fact for David R. Purdue
- Signature date
- 11 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABBV
transaction
Common Stock, $0.01 par value
Tax liability
- Transaction value
- Shares
- -2,108
- Change %
- -20%
- Price
- $232.08*
- Shares after
- 8,468
- Date
- 27 Feb 2026
- Ownership
- Direct
ABBV
holding
Common Stock, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 543
- Date
- 27 Feb 2026
- Ownership
- Profit sharing trust
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature.
SEC remarks
Amended to correct the number of shares withheld for taxes at vesting as reported on the original Form 4 filed March 3, 2026. The original filing reflected an incorrect withholding rate. All other information remains unchanged.